Genmab | GEN - Interest Expense On Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Genmab

Genmab reported DKK6M in Interest Expense on Debt for its fiscal quarter ending in March of 2023.


Interest Expense On Debt Change
Amgen AMGN:US USD 543M 128M
BioMarin Pharmaceutical BMRN:US USD 3.7M 77K
Genmab GEN:DC DKK 6M 1000K
Immunogen IMGN:US USD 853K 118K
Insmed INSM:US USD 20.08M 3.63M
Lonza Group LONN:SW CHF 32M 4M
Novartis NOVN:VX USD 211M 8M
Regeneron Pharmaceuticals REGN:US USD 18M 600K
Roche Holding ROG:VX CHF 348M 92M